Solta Medical (SLTM) +5.8% premarket after providing an update of the launch of its FDA-approved...

|About: Solta Medical, Inc (SLTM)|By:, SA News Editor

Solta Medical (SLTM) +5.8% premarket after providing an update of the launch of its FDA-approved Liposonix non-invasive fat reduction system. SLTM says it is on track to meet or exceed 2012 revenue guidance, and the majority of key opinion leaders who received Liposonix systems have successfully evaluated and purchased the product.